This clear lack of research into understanding the regulation of iron parameters and hepcidin in active premenopausal females throughout their menstrual cycle has limited the creation of clear practical recommendations to improve the diagnosis, management, and treatment of iron deficiency in this at risk cohort. This evidence concerns the gene HAMP and nutritional disorder.